Company Data

Eledon Pharmaceuticals

Fundamental Analysis:

Eledon Pharmaceuticals

Eledon Pharmaceuticals
Fundamental Analysis:
Ticker
ELDN
Current Price
$1.14 -0.87%
Market Cap
$27.6M
Price Target
Refer to Report
Volume
38.5K
52wk Range
$1.07 - $3.7
Advanced Market Data

Overview

Eledon Pharmaceuticals is a clinical stage biotechnology company with immunology expertise that is developing therapies to protect and prevent rejection of transplanted organs, as well as to treat amyotrophic lateral sclerosis (ALS). The Company’s lead compound in development is tegoprubart, an anti-CD40L antibody with high affinity for CD40 Ligand, a well-validated biological target with broad therapeutic potential. Eledon is headquartered in Irvine, California. For more information, please visit the company’s website at www.eledon.com.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy
© 2018-2023 Noble Financial Group, Inc. All Rights Reserved. Channelchek is provided at no cost to be used for information purposes only and not as investment advisement.